Postinfection Metabolic Reprogramming of the Murine Trigeminal Ganglion Limits Herpes Simplex Virus-1 Replication

Chandrashekhar D Patil1, Rahul K Suryawanshi1, Divya Kapoor1,2

  • 1Department of Ophthalmology and Visual Sciences, University of Illinois at Chicagogrid.185648.6, Chicago, Illinois, USA.

Mbio
|August 31, 2022
PubMed

Insights

Herpes simplex virus type-1 (HSV-1) alters host metabolism in the trigeminal ganglion during infection. This study reveals metabolic changes that may help the virus establish latency and reactivate.

Area of Science:

  • Virology
  • Metabolomics
  • Neuroscience

Background:

  • Herpes simplex virus type-1 (HSV-1) efficiently propagates by altering host metabolism in vitro.
  • In vivo metabolic changes during prolonged HSV-1 infection, particularly in the trigeminal ganglion (TG), are poorly understood.
  • HSV-1 establishes lifelong latency in the TG, leading to ocular pathologies like herpetic keratitis.

Purpose of the Study:

  • To investigate the metabolic alterations in the trigeminal ganglion (TG) during prolonged corneal HSV-1 infection in a murine model.
  • To identify key metabolic pathways and products regulated by HSV-1 infection in the TG.
  • To understand the role of metabolic perturbations in HSV-1 latency and reactivation.

Main Methods:

  • High-resolution liquid chromatography coupled with mass spectrometry (LC-MS) for metabolomics analysis of TG tissue.
  • Functional assays and targeted inhibition of metabolic pathways.
  • In vivo, in vitro, and ex vivo experimental models.

Main Results:

  • HSV-1 infection significantly altered the host metabolic profile in the TG.
  • Downregulation of central carbon metabolism and nucleotide synthesis pathways was observed post-infection.
  • Targeted inhibition of identified polyamine pathways validated the metabolomics findings.

Conclusions:

  • HSV-1 infection reprograms host metabolism in the TG, limiting energy and precursor availability for viral replication.
  • Metabolic dysregulation is implicated in the establishment and maintenance of HSV-1 latency.
  • Understanding these metabolic perturbations could reveal novel therapeutic targets against HSV-1.